Veterinary drugs based on recombinant regulatory animal proteins

Purpose

The product line includes three types of veterinary drugs based on recombinant regulatory animal proteins. They can be monocomponent, biocomponent and multicomponent and each of them has its own purpose.

Characteristics

- Increase in lysozyme and bactericidal activities of blood serum
- Anti-toxic and anti-stress effect
- Stimulation of macrophages and phagocytosis
- Increased antibodies production; activation of natural killer cells
- Stimulation of histamine release by basophils
- Suppression of delayed-type hypersensitivity

• Monocomponent veterinary drugs contain interferon as the active ingredient. The drugs are designed for the prevention and treatment of viral etiology diseases they can be used as immunostimulants, antistress factors, amplifiers of vaccines and antibiotics action and means for the withdrawal of immunosuppressive effects.

• Biocomponent veterinary drugs of durable action contain interferon and an antibacterial agent (antibiotic) as the active ingredient. The drugs are designed for prevention and treatment of mixed bacterial and viral infections.

• Multicomponent veterinary drugs contain interferon and a complex of vitamins A, D3, E and C in their optimum physiological ratios which serve as the active ingredient. They have a strong synergistic effect as they amplify the effects of both interferon and vitamins.

Application

Agriculture, veterinary science

Offer

Final product sale, technology sale, joint production

See other available veterinary drugs produced on the BSU base:

Veterinary drugs for animals microelementhoses treatment FEROVET, KUPROVET, KOBALVET, TSINKOVET